WVE
Wave Life SciencesDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
WVE vs peer average
39/100
WVE vs. peer average (D vs. C)
Grade spread
B 2 · C 3 · D 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
BEAM is the first available peer comparator.
Beam is the closest platform-style peer in the packet because it is also a high-risk gene/RNA editing name where clinical proof and regulatory credibility drive valuation. If Wave can turn WVE-006 into a clearer registrational path, the market may again reward platform optionality; until then both trade on milestone timing and data quality more than on near-term revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
WVE
Wave Life Sciences
BEAM
Beam Therapeutics
Grade
D
C
Momentum
6
43
Value
41
41
Sentiment
75
72
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs BEAM
WVE / BEAM
Grade Position
Below peers
WVE vs. peer average (D vs. C)
39/100
Momentum
6
BEAMValue
41
WVESentiment
75
WVERotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs WVE
BEAM is the first peer returned for this comparison set.